Abstract
The tendency of the proteins to aggregate (i.e., their so-called Lego property) is viewed as a necessary feature of proteins to build up molecular networks, which are the informational substrate that allows integrative actions of cells and hence of tissues. Thus, the concept of physiological protein mosaics is discussed not only as the basis for the formation of structural elements of the cell and of the extra-cellular matrix, but also as the main component of molecular networks. Against this background, the hypothesis is introduced that prion-like properties of some proteins have a possible physiological meaning for the formation of physiological protein mosaics and hence of complex molecular networks. Protein misfolding and the Lego property can favour the formation of unwanted protein aggregates. On this basis, the concept of pathological mosaics is introduced as the most frequent consequence of alterations in the three dimensional structures of proteins, thus representing a feature characterising the conformational protein diseases. It is postulated that pathological protein mosaics affect the structure and function of the global molecular network enmeshing the whole central nervous system leading to neurodegenerative disease, the most clear cut example being Prion disease.
Keywords: Protein mosaics, protein misfolding, global molecular network, central nervous system, prion disease, neurodegenerative diseases
Current Proteomics
Title: The Concept of Protein Mosaics: Physiological Role and Relevance for Prion Disease
Volume: 3 Issue: 3
Author(s): Luigi Francesco Agnati, Susanna Genedani, Chiara Carone, Giuseppina Leo and Kjell Fuxe
Affiliation:
Keywords: Protein mosaics, protein misfolding, global molecular network, central nervous system, prion disease, neurodegenerative diseases
Abstract: The tendency of the proteins to aggregate (i.e., their so-called Lego property) is viewed as a necessary feature of proteins to build up molecular networks, which are the informational substrate that allows integrative actions of cells and hence of tissues. Thus, the concept of physiological protein mosaics is discussed not only as the basis for the formation of structural elements of the cell and of the extra-cellular matrix, but also as the main component of molecular networks. Against this background, the hypothesis is introduced that prion-like properties of some proteins have a possible physiological meaning for the formation of physiological protein mosaics and hence of complex molecular networks. Protein misfolding and the Lego property can favour the formation of unwanted protein aggregates. On this basis, the concept of pathological mosaics is introduced as the most frequent consequence of alterations in the three dimensional structures of proteins, thus representing a feature characterising the conformational protein diseases. It is postulated that pathological protein mosaics affect the structure and function of the global molecular network enmeshing the whole central nervous system leading to neurodegenerative disease, the most clear cut example being Prion disease.
Export Options
About this article
Cite this article as:
Francesco Agnati Luigi, Genedani Susanna, Carone Chiara, Leo Giuseppina and Fuxe Kjell, The Concept of Protein Mosaics: Physiological Role and Relevance for Prion Disease, Current Proteomics 2006; 3 (3) . https://dx.doi.org/10.2174/157016406779475362
DOI https://dx.doi.org/10.2174/157016406779475362 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Provoking Neuroprotection by Peroxynitrite
Current Pharmaceutical Design Protein Profile Analysis of Two Australian Snake Venoms by One- Dimensional Gel Electrophoresis and MS/MS Experiments
Current Medicinal Chemistry Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities
Recent Patents on Inflammation & Allergy Drug Discovery Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding
Current Pharmaceutical Design A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry The Cell Wall-Associated Proteins in the Dimorphic Pathogenic Species of Paracoccidioides
Current Protein & Peptide Science Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Vitamin D in Acute Kidney Injury
Inflammation & Allergy - Drug Targets (Discontinued) Opioid Withdrawal Syndrome: Emerging Concepts and Novel Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Recent Advances in Analytical Techniques used for the Determination of Fluoroquinolones in Pharmaceuticals and Samples of Biological Origin - A Review Article
Current Pharmaceutical Analysis Understanding the Dual Inhibition of COX-2 and Carbonic Anhydrase-II by Celecoxib and CG100649 Using Density Functional Theory Calculations and other Molecular Modelling Approaches
Protein & Peptide Letters Plant- and Nutraceutical-based Approach for the Management of Diabetes and its Neurological Complications: A Narrative Review
Current Pharmaceutical Design Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development
Current Medicinal Chemistry Controversies in the Pharmacological Treatment of Uveitis
Current Pharmaceutical Design Proteasome Function in Antigen Presentation: Immunoproteasome Complexes, Peptide Production, and Interactions with Viral Proteins
Current Protein & Peptide Science Biomarkers for Predicting the Immunomodulatory Properties of Probiotics
Recent Patents on Biomarkers Anti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Peptide Mimetics Based on N-protected Amino Acids Derived from Isomannide as Potential Inhibitors of NS3 Serine Protease of Hepatitis C Virus
Letters in Organic Chemistry Glycobiology in Malignant Gliomas: Expression and Functions of Galectins and Possible Therapeutic Options
Current Pharmaceutical Biotechnology Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry